UroGen Pharma Ltd.URGNNASDAQ
LOADING
|||
Cash Flow Under Pressure
Trending lower, below historical average, strong compound growth.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-97.06M
↓ 68% below average
Average (9y)
$-57.72M
Historical baseline
Range
High:$3.49M
Low:$-107.10M
CAGR
+33.0%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-97.06M | -26.8% |
| 2023 | $-76.57M | +12.8% |
| 2022 | $-87.81M | -2.5% |
| 2021 | $-85.64M | +20.0% |
| 2020 | $-107.10M | -50.1% |
| 2019 | $-71.34M | -88.3% |
| 2018 | $-37.89M | -285.0% |
| 2017 | $-9.84M | -381.7% |
| 2016 | $3.49M | +146.7% |
| 2015 | $-7.48M | - |